Article Details
Retrieved on: 2024-06-18 13:56:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Tuesday, AstraZeneca Plc NASDAQ:AZN announced topline data from the CAPItello-290 Phase 3 trial for Truqap (capivasertib) in combination with ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here